Health authorities are implementing a vaccination initiative aimed at protecting approximately one million teenagers and young adults against meningitis B, citing elevated infection concerns. The programme will focus on individuals identified as facing the highest immediate risk, including Year 13 pupils and those under 25 entering university or residential further education this autumn.
Meningitis is an infection affecting the membranes surrounding the brain and spinal cord. While it can affect individuals of any age, it occurs most frequently in babies, young children, teenagers and young adults. The condition can prove life-threatening if not treated promptly. Official data indicate there were 378 cases of invasive meningococcal disease documented in the period 2024-2025. Meningitis B, or MenB, accounts for the majority of more severe meningococcal disease cases in the UK. Symptoms develop rapidly and may include sudden high fever, severe headache, neck stiffness, rash that doesn’t fade when pressed, vomiting, diarrhoea, joint and muscle pain, sensitivity to light, cold extremities, seizures, and confusion.
The infection spreads through close personal contact, with transmission occurring via saliva exchange during coughs, sneezes, kissing, or sharing food and beverages. Individuals carrying the bacteria in their nose or throat may transmit the infection without experiencing illness themselves. University settings and shared accommodation environments present heightened transmission risk, as invasive meningococcal disease peaks seasonally in October through November.
Two primary vaccines protect against major causes of meningitis. The MenB vaccine is recommended for infants beginning at eight weeks of age, with subsequent doses at 12 weeks and one year. The MenACWY vaccine protects against four bacterial types and is offered to teenagers aged 14, with free access available until age 25. Additional vaccines, including those for pneumococcal disease, diphtheria, tetanus, measles, mumps and rubella, also provide protective benefits. The one-off vaccination programme this summer will offer two free MenB doses to eligible young people through the NHS.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI